Related Experiment Video
Updated: Aug 31, 2025

Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Rapidly-Developing Pleural Effusion: Explosive Pleuritis Caused by Group A Streptococcal Infection
Haris Asif1, Mateus Fernandes1, Allen Gorbonos1
1Internal Medicine, Woodhull Medical Center, New York City, USA.
Abstract:
Community-acquired pneumonia is a leading cause of death from infectious diseases globally. Parapneumonic effusion is one of the most common complications of community-acquired pneumonia. As the infection progresses within the pleural space, loculation and empyema may develop. In rare cases, the parapneumonic effusions can progress significantly within 24 hours, which has been described as explosive pleuritis and may confer additional morbidity. Group A Streptococcus is the leading causative microorganism, which in itself has higher rates of parapneumonic effusions. We describe the case of a 30-year-old-female with a past medical history of asthma who presented to the emergency department with a sore throat, cough, and runny nose and was discharged on the same day after treatment of asthma exacerbation with upper respiratory tract infection. She re-presented within 24 hours with shortness of breath and right-sided pleuritic chest pain. Chest x-ray showed a new, large right-sided pleural effusion for which pleural fluid culture grew group A Streptococcus. She ultimately had prolonged hospitalization, requiring chest tube placement, and video-assisted thoracoscopic surgery (VATS). VATS was unsuccessful and she was treated with long-term antibiotics. This case demonstrates the dramatic evolution of explosive pleuritis and highlights the typical challenges encountered in these cases.
Insights
Explosive pleuritis, a rapid progression of parapneumonic effusion, can occur within 24 hours. Group A Streptococcus is a common cause, leading to severe complications and prolonged treatment.
Area of Science:
- Infectious Diseases
- Pulmonology
- Critical Care Medicine
Background:
- Community-acquired pneumonia (CAP) is a significant global cause of infectious disease mortality.
- Parapneumonic effusion (PPE) is a frequent complication of CAP, potentially progressing to empyema.
- Explosive pleuritis, characterized by rapid PPE progression within 24 hours, increases morbidity.
Observation:
- Group A Streptococcus (GAS) is a primary pathogen in PPE, associated with higher effusion rates.
- A case study details a 30-year-old female with asthma presenting with GAS-related explosive pleuritis.
- Initial symptoms included URI, followed by rapid onset of shortness of breath and pleuritic chest pain.
Findings:
- Chest X-ray revealed a large, new right-sided pleural effusion.
- Pleural fluid culture confirmed Group A Streptococcus as the causative agent.
- The patient required prolonged hospitalization, chest tube placement, and failed video-assisted thoracoscopic surgery (VATS).
Implications:
- This case underscores the rapid and severe progression of GAS-associated explosive pleuritis.
- Challenges in managing such aggressive infections are highlighted.
- Effective treatment strategies for explosive pleuritis remain critical in clinical practice.
Related Concept Videos
Pleural Effusion I: Introduction
There are two main types of pleural effusion: transudative and exudative. They are differentiated using Light's...
Pleural Effusion II: Symptoms and Management
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
Pneumothorax-II
Clinical Manifestations:
Pneumonia III: Complications and Assessment
Rheumatic Heart Disease I: Introduction
Pneumonia II: Pathophysiology

